Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Christy J. Wilson
Sr. Director, Pharma and Biotech Segment
Connect with Christy J. Wilson on LinkedIn
Follow Christy J. Wilson on Twitter
About the author:
Christy brings more than 20 years of global life science and healthcare industry experience to her role as Senior Director, Segment Marketing for the biopharmaceutical industry segment at Elsevier. In this capacity she is focused on understanding biopharmaceutical R&D challenges and the implications for Elsevier in terms of market led growth opportunities that will improve productivity and success for industry executives and their teams. She also plays a key role in increasing Elsevier’s share-of-voice and market share through strategic go-to-market planning and execution.
Prior to joining Elsevier, Christy held senior marketing and business development roles in Wolters Kluwer’s Pharma Solutions Business Unit where she was responsible for product management and marketing of the Adis portfolio of drug focused journals and newsletters, pipeline and clinical trials intelligence tools, and pharmacovigilance solutions. During her Wolters Kluwer tenure, Christy also worked in the group’s Healthcare Analytics business, a business that provided powerful data, applications, analytics, and consulting to help companies gain deep insight into the pharmaceutical market.
Christy resides in the greater New York City area and holds an MBA in International Business from DePaul University (Chicago) and a BS in Marketing, from Miami University (Ohio).
Posts by Christy J. Wilson
Posted on March 13th, 2017 in Pharma R&D
Precision medicine, which takes the individual into account like never before, has been a thrilling development in the field of medicinal research. It is an area that has shown particular promise in the treatment of cancer, Continue reading “Making Medicine More Precise” »
Posted on February 1st, 2017 in Pharma R&D
The top blogs in this category reflect just how much politics and current events can mean to the health of the pharmaceutical industry, Continue reading “5 most popular Pharma R&D blog posts of 2016” »
Posted on January 9th, 2017 in Pharma R&D
Although the pharmaceutical industry has invested a great deal in data-producing technologies (e.g. next-generation and single cell sequencing), it has been slower to invest in the data management and analytics technologies Continue reading “How Bioinformatics is Boosting Precision Medicine” »
Posted on November 16th, 2016 in Pharma R&D
There are about 7,000 diseases out there that are considered “rare,” but they actually affect hundreds of millions of people worldwide – nearly half of whom are children. Continue reading “Collaborating to Treat Rare Diseases” »